Semi-Annual Statement Of Income

Chordia Therapeutics,Inc - Filing #7267458

Concept 2024-09-01 to
2025-02-28
2023-09-01 to
2024-02-29
Semi-annual statement of income
Statement of income
Ordinary profit (loss)
-975,131,000 JPY
-801,401,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
22,900,000 JPY
22,500,000 JPY
Depreciation
361,000 JPY
462,000 JPY
Profit (loss) before income taxes
-975,131,000 JPY
-801,401,000 JPY
Operating profit (loss)
-996,358,000 JPY
-809,656,000 JPY
Income taxes - current
1,210,000 JPY
1,210,000 JPY
Non-operating income
23,907,000 JPY
11,444,000 JPY
Non-operating income
Non-operating expenses
2,680,000 JPY
3,189,000 JPY
Income taxes
1,210,000 JPY
1,210,000 JPY
Profit (loss)
-976,341,000 JPY
-802,611,000 JPY
Non-operating expenses

Talk to a Data Expert

Have a question? We'll get back to you promptly.